It is possible to speculate that the increase in circulating ANGPT1 in all patients with mastocytosis might represent a protective factor in counterbalancing the vasopermeability effect of VEGF-A [41, 42, 82] and ANGPT2 [61]. The gene discussed is ANGPT2; the disease is mastocytosis.